Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Microbiol Infect ; 15(11): 1046-50, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19548926

RESUMO

To evaluate in routine hospital practice the clinical response to ertapenem in comparison with other parenteral antibiotics in the treatment of community-acquired pneumonia (CAP), clinical records from patients with severe CAP treated with ertapenem from July 2002 to June 2006 in seven Spanish hospitals were retrospectively reviewed. Patients were classified according to the Pneumonia Severity Index (PSI). Each ertapenem-treated patient was matched with two patients in the same hospital treated with other antibiotics, according to age (difference 76 years). Comorbidities were present in 193 patients (95.5%). No differences were found in median hospital stay (7 days for ertapenem vs. 10 days for comparators, p 0.066). A slightly higher clinical response rate was obtained for ertapenem vs. comparators (88.7% vs. 77.1%; p 0.0465; OR 2.25; 95% CI 0.99-5.12), with significant differences in clinical response in patients coming from nursing homes (95.8% ertapenem vs. 63.8% comparators; p 0.0034) but not in non-institutionalized patients (85.4% ertapenem vs. 84.5% comparators; p 0.929). The higher clinical response to ertapenem vs. comparators in severe CAP was due to its significantly higher efficacy in healthcare-associated CAP in patients coming from nursing homes.


Assuntos
Antibacterianos/uso terapêutico , Infecções Comunitárias Adquiridas/tratamento farmacológico , Pneumonia/tratamento farmacológico , beta-Lactamas/uso terapêutico , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Infecções Comunitárias Adquiridas/patologia , Infecções Comunitárias Adquiridas/fisiopatologia , Ertapenem , Feminino , Hospitais , Humanos , Tempo de Internação , Masculino , Pneumonia/patologia , Pneumonia/fisiopatologia , Estudos Retrospectivos , Índice de Gravidade de Doença , Espanha , Resultado do Tratamento
4.
An Med Interna ; 14(4): 187-9, 1997 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-9181815

RESUMO

Eosinophilic gastroenteritis is an uncommon disorder, characterised by eosinophilic infiltration of gut wall, with variable clinical features, depending affected layer of the wall and digestive area, but usually consisting in abdominal pain, diarrhoea, and vomiting. Etiopathogenesis is unknown, with a frequent allergic condition and good response to corticosteroids therapy. Although the existence of eosinophilic gastroenteritis may be suggested by abdominal manifestations, an allergic history with laboratory date and ESR normal, only the antral or intestinal biopsy might to confirm the diagnostic. We report a case of a patient with eosinophilic gastroenteritis and history of bronchial asthma, without evidence of intestinal parasitosis, and a spectacular response to corticosteroids therapy.


Assuntos
Eosinofilia/diagnóstico , Gastroenterite/diagnóstico , Biópsia , Duodeno/patologia , Eosinofilia/tratamento farmacológico , Eosinofilia/patologia , Mucosa Gástrica/patologia , Gastroenterite/tratamento farmacológico , Gastroenterite/patologia , Glucocorticoides/administração & dosagem , Humanos , Masculino , Pessoa de Meia-Idade , Prednisona/administração & dosagem , Indução de Remissão
5.
Arch Esp Urol ; 50(9): 1007-9, 1997 Nov.
Artigo em Espanhol | MEDLINE | ID: mdl-9527819

RESUMO

OBJECTIVE: To describe a case of incarcerated inguinal hernia containing bladder carcinoma. METHODS/RESULTS: A case of urothelial bladder neoplasm presenting with perforation and scrotal abscess is described. The clinical features, incidence and diagnostic aspects are discussed and the literature briefly reviewed. CONCLUSION: The association of malignant tumor and hernia of the abdominal wall is uncommon, particularly those involving the inguinal zone. To our knowledge, only 8 cases have been reported from 1965 to 1995, accounting for 5.3% of all hernia sac-associated tumors. The location of this type of tumor delays diagnosis and the outcome is generally poor.


Assuntos
Carcinoma de Células de Transição/complicações , Hérnia Inguinal/complicações , Neoplasias da Bexiga Urinária/complicações , Idoso , Humanos , Masculino
8.
J Clin Pathol ; 48(6): 579-82, 1995 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-7665707

RESUMO

A case of idiopathic granulomatous vasculitis (disseminated visceral giant cell arteritis) is described in an old woman, the seventh case of this rare disorder reported to date. The main organ affected was the liver and, to our knowledge, this is the first patient to be diagnosed while still alive and the only case to have received medical treatment. It is also the first time that muscular involvement has been documented in this condition. Cyclophosphamide treatment resulted in disappearance of symptoms and increase in weight. The patient died of an unrelated condition.


Assuntos
Ciclofosfamida/uso terapêutico , Arterite de Células Gigantes/tratamento farmacológico , Hepatopatias/tratamento farmacológico , Doenças Musculares/tratamento farmacológico , Idoso , Feminino , Humanos
9.
An Med Interna ; 12(3): 130-2, 1995 Mar.
Artigo em Espanhol | MEDLINE | ID: mdl-7795120

RESUMO

Langerhans' cell granulomatosis is a usually benign disease, characterized by the proliferation of Langerhans' cell containing S-100 protein. Disease is related with the smoking habit and immunological alterations, and is able to affect any organ in isolated or multisystem form. Diagnosis is provided by biopsy of the lesion and bronchoalveolar lavage if the lung is injured. We present a case of a smoker man with lytic lesion in the skull, which biopsy was diagnostic, and with an asymptomatic interstitial infiltrates lungs, with a restrictive spirometry. Remission was achieved with prednisone (0.75 mg x kg) and stop smoking.


Assuntos
Doenças Ósseas/patologia , Histiocitose de Células de Langerhans/patologia , Pulmão/patologia , Adulto , Histiocitose de Células de Langerhans/tratamento farmacológico , Humanos , Masculino , Osteólise/patologia , Prednisona/uso terapêutico , Crânio/patologia , Fumar/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...